Immediate Impact
2 from Science/Nature 89 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
2023 Standout
Works of Jinlu Shan being referenced
Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.
2023
Cation-exchange antibody labeling for simultaneous electrochemical detection of tumor markers CA15-3 and CA19-9
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jinlu Shan | 427 | 191 | 162 | 39 | 739 | |
| Wen‐Hui Weng | 296 | 119 | 125 | 47 | 679 | |
| Jingjing Miao | 254 | 213 | 105 | 42 | 727 | |
| Yanjun Li | 371 | 110 | 115 | 44 | 756 | |
| Mark Gray | 313 | 191 | 151 | 39 | 808 | |
| Fangqin Xue | 363 | 75 | 95 | 36 | 684 | |
| Yulian Wu | 397 | 167 | 66 | 41 | 815 | |
| Xiaomin Fu | 374 | 144 | 48 | 38 | 713 | |
| Boran Cheng | 260 | 371 | 117 | 29 | 829 | |
| Tao Guo | 247 | 344 | 128 | 62 | 832 | |
| Guolin Yuan | 322 | 289 | 42 | 42 | 806 |
All Works
Loading papers...